Clinical Trial Update: TRIple in asthMA With uncontRolled pAtient on Medium streNgth of ICS + LABA [Phase 3]

View source ↗

Summary

Phase 3 trial update for triple therapy in uncontrolled asthma patients on medium-dose inhaled corticosteroids with LABA has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Asthma | Phase 3 | Status: COMPLETED